131 related articles for article (PubMed ID: 16248655)
1. Understanding how the herpes thymidine kinase orchestrates optimal sugar and nucleobase conformations to accommodate its substrate at the active site: a chemical approach.
Marquez VE; Choi Y; Comin MJ; Russ P; George C; Huleihel M; Ben-Kasus T; Agbaria R
J Am Chem Soc; 2005 Nov; 127(43):15145-50. PubMed ID: 16248655
[TBL] [Abstract][Full Text] [Related]
2. Sculpting the bicyclo[3.1.0]hexane template of carbocyclic nucleosides to improve recognition by herpes thymidine kinase.
Comin MJ; Agbaria R; Ben-Kasus T; Huleihel M; Liao C; Sun G; Nicklaus MC; Deschamps JR; Parrish DA; Marquez VE
J Am Chem Soc; 2007 May; 129(19):6216-22. PubMed ID: 17451242
[TBL] [Abstract][Full Text] [Related]
3. Understanding the binding of 5-substituted 2'-deoxyuridine substrates to thymidine kinase of herpes simplex virus type-1.
De Winter H; Herdewijn P
J Med Chem; 1996 Nov; 39(24):4727-37. PubMed ID: 8941385
[TBL] [Abstract][Full Text] [Related]
4. Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of Herpes simplex virus type 1 thymidine kinase interacting with (North)-methanocarba-thymidine.
Prota A; Vogt J; Pilger B; Perozzo R; Wurth C; Marquez VE; Russ P; Schulz GE; Folkers G; Scapozza L
Biochemistry; 2000 Aug; 39(31):9597-603. PubMed ID: 10924157
[TBL] [Abstract][Full Text] [Related]
5. Nucleoside binding site of herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography.
Vogt J; Perozzo R; Pautsch A; Prota A; Schelling P; Pilger B; Folkers G; Scapozza L; Schulz GE
Proteins; 2000 Dec; 41(4):545-53. PubMed ID: 11056041
[TBL] [Abstract][Full Text] [Related]
6. Rearranging the bicyclo[3.1.0]hexane template of carbocyclic nucleosides to improve binding recognition by kinases.
Marquez VE; Comin MJ
Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):585-8. PubMed ID: 18066860
[TBL] [Abstract][Full Text] [Related]
7. Some 6-aza-5-substituted-2'-deoxyuridines show potent and selective inhibition of herpes simplex virus type 1 thymidine kinase.
Basnak I; Sun M; Hamor TA; Focher F; Verri A; Spadari S; Wroblowski B; Herdewijn P; Walker RT
Nucleosides Nucleotides; 1998; 17(1-3):187-206. PubMed ID: 9708347
[TBL] [Abstract][Full Text] [Related]
8. Mutations distal to the substrate site can affect varicella zoster virus thymidine kinase activity: implications for drug design.
El Omari K; Liekens S; Bird LE; Balzarini J; Stammers DK
Mol Pharmacol; 2006 Jun; 69(6):1891-6. PubMed ID: 16556772
[TBL] [Abstract][Full Text] [Related]
9. Bicyclic nucleoside inhibitors of varicella-zoster virus modified on the sugar moiety: 3' and 5' derivatives.
Luoni GM; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2004 Nov; 15(6):333-41. PubMed ID: 15646647
[TBL] [Abstract][Full Text] [Related]
10. 6-azapyrimidine-2'-deoxy-4'-thionucleosides: antiviral agents against TK+ and TK- HSV and VZV strains.
Maslen HL; Hughes D; Hursthouse M; De Clercq E; Balzarini J; Simons C
J Med Chem; 2004 Oct; 47(22):5482-91. PubMed ID: 15481985
[TBL] [Abstract][Full Text] [Related]
11. Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase.
Sienaert R; Andrei G; Snoeck R; De Clercq E; McGuigan C; Balzarini J
Biochem Biophys Res Commun; 2004 Mar; 315(4):877-83. PubMed ID: 14985094
[TBL] [Abstract][Full Text] [Related]
12. Experimental and structural evidence that herpes 1 kinase and cellular DNA polymerase(s) discriminate on the basis of sugar pucker.
Marquez VE; Ben-Kasus T; Barchi JJ; Green KM; Nicklaus MC; Agbaria R
J Am Chem Soc; 2004 Jan; 126(2):543-9. PubMed ID: 14719951
[TBL] [Abstract][Full Text] [Related]
13. Novel 1,2,4-triazole and purine acyclic cyclopropane nucleoside analogues: synthesis, antiviral and cytostatic activity evaluations.
Benci K; Suhina T; Mandić L; Pavelić SK; Paravić AT; Pavelić K; Balzarini J; Wittine K; Mintas M
Antivir Chem Chemother; 2011 Jul; 21(6):221-30. PubMed ID: 21730369
[TBL] [Abstract][Full Text] [Related]
14. Exploring the active site of herpes simplex virus type-1 thymidine kinase by X-ray crystallography of complexes with aciclovir and other ligands.
Champness JN; Bennett MS; Wien F; Visse R; Summers WC; Herdewijn P; de Clerq E; Ostrowski T; Jarvest RL; Sanderson MR
Proteins; 1998 Aug; 32(3):350-61. PubMed ID: 9715911
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the binding mode of N2-phenylguanine derivative inhibitors to herpes simplex virus type 1 thymidine kinase.
Gaudio AC; Takahata Y; Richards WG
J Comput Aided Mol Des; 1998 Jan; 12(1):15-25. PubMed ID: 9570086
[TBL] [Abstract][Full Text] [Related]
16. N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors.
Hernandez AI; Familiar O; Negri A; Rodríguez-Barrios F; Gago F; Karlsson A; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
J Med Chem; 2006 Dec; 49(26):7766-73. PubMed ID: 17181158
[TBL] [Abstract][Full Text] [Related]
17. The rational of catalytic activity of herpes simplex virus thymidine kinase. a combined biochemical and quantum chemical study.
Sulpizi M; Schelling P; Folkers G; Carloni P; Scapozza L
J Biol Chem; 2001 Jun; 276(24):21692-7. PubMed ID: 11262392
[TBL] [Abstract][Full Text] [Related]
18. Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design.
El Omari K; Solaroli N; Karlsson A; Balzarini J; Stammers DK
BMC Struct Biol; 2006 Oct; 6():22. PubMed ID: 17062140
[TBL] [Abstract][Full Text] [Related]
19. North- and south-bicyclo[3.1.0]hexene nucleosides: the effect of ring planarity on anti-HIV activity.
Russ PL; Gonzalez-Moa MJ; Vu BC; Sigano DM; Kelley JA; Lai CC; Deschamps JR; Hughes SH; Marquez VE
ChemMedChem; 2009 Aug; 4(8):1354-63. PubMed ID: 19533724
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of conformationally restricted 2',3'-exo-methylene carbocyclic nucleosides built on a bicyclo[3.1.0]hexane template.
Bhushan RG; Vince R
Bioorg Med Chem; 2002 Jul; 10(7):2325-33. PubMed ID: 11983530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
